Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yafen Li

Showing results (51-60 of 101) with videos related to

Pageof 11
Sort By:
Gland Surgery|December 18, 2023
Safety analysis of immediate breast reconstruction with a deep inferior epigastric perforator (DIEP) flap in the post-COVID-19 era: a comparison between pre- and post-pandemic cohortsWeiqi Gao, Yujie Lu, Ou Huang, et al.
Amino Acids|March 7, 2015
Targeting rho guanine nucleotide exchange factor ARHGEF5/TIM with auto-inhibitory peptides in human breast cancerOu Huang, Dandan Wu, Feiyan Xie, et al.
Molecular and Clinical Oncology|October 4, 2014
Long-term outcomes following adjuvant endocrine therapy in breast cancer patients with a positive-to-negative change of hormone receptor status following neoadjuvant chemotherapyJia Yi Wu, Wei Guo Chen, Xiao Song Chen, et al.
Annals of Surgical Oncology|February 8, 2017
Can Clinically Node-Negative Breast Cancer Patients with Suspicious Axillary Lymph Nodes at Ultrasound But Negative Fine-Needle Aspiration Be Approached as Having Node-Negative Disease?Yue Liang, Xiaosong Chen, Weiwei Zhan, et al.
Journal of Cancer Research and Clinical Oncology|May 16, 2019
Invasive ductal carcinoma with coexisting ductal carcinoma in situ (IDC/DCIS) versus pure invasive ductal carcinoma (IDC): a comparison of clinicopathological characteristics, molecular subtypes, and clinical outcomesChih Wan Goh, Jiayi Wu, Shuning Ding, et al.
Frontiers in Pharmacology|December 30, 2022
Potential drug-drug interaction of olverembatinib (HQP1351) using physiologically based pharmacokinetic modelsZhiheng Yu, Zihan Lei, Xueting Yao, et al.
Frontiers in Oncology|October 12, 2020
A Novel Prognostic Scoring System Integrating Gene Expressions and Clinicopathological Characteristics to Predict Very Early Relapse in Node-Negative Estrogen Receptor-Positive/HER2-Negative Breast CancerCaijin Lin, Jiayi Wu, Lin Lin, et al.
Frontiers in Oncology|February 11, 2026
MiR-424-5p acts as an oncogene in Hep3B cells by activating the PI3K/AKT signaling pathwayZhixian Ding, Shuaiyong Qi, Mengxue Hu, et al.
Frontiers in Oncology|February 2, 2023
Impact of clinicopathological factors on extended endocrine therapy decision making in estrogen receptor-positive breast cancerWeilin Chen, Jiayi Wu, Yifei Zhu, et al.
Biomedical Physics & Engineering Express|February 5, 2021
Synthesizing CT images from MR images with deep learning: model generalization for different datasets through transfer learningWen Li, Samaneh Kazemifar, Ti Bai, et al.
Pageof 11

Showing results (51-60 of 101) with videos related to

Sort By:
Pageof 11
Gland Surgery|December 18, 2023
Safety analysis of immediate breast reconstruction with a deep inferior epigastric perforator (DIEP) flap in the post-COVID-19 era: a comparison between pre- and post-pandemic cohortsWeiqi Gao, Yujie Lu, Ou Huang, et al.
Amino Acids|March 7, 2015
Targeting rho guanine nucleotide exchange factor ARHGEF5/TIM with auto-inhibitory peptides in human breast cancerOu Huang, Dandan Wu, Feiyan Xie, et al.
Molecular and Clinical Oncology|October 4, 2014
Long-term outcomes following adjuvant endocrine therapy in breast cancer patients with a positive-to-negative change of hormone receptor status following neoadjuvant chemotherapyJia Yi Wu, Wei Guo Chen, Xiao Song Chen, et al.
Annals of Surgical Oncology|February 8, 2017
Can Clinically Node-Negative Breast Cancer Patients with Suspicious Axillary Lymph Nodes at Ultrasound But Negative Fine-Needle Aspiration Be Approached as Having Node-Negative Disease?Yue Liang, Xiaosong Chen, Weiwei Zhan, et al.
Journal of Cancer Research and Clinical Oncology|May 16, 2019
Invasive ductal carcinoma with coexisting ductal carcinoma in situ (IDC/DCIS) versus pure invasive ductal carcinoma (IDC): a comparison of clinicopathological characteristics, molecular subtypes, and clinical outcomesChih Wan Goh, Jiayi Wu, Shuning Ding, et al.
Frontiers in Pharmacology|December 30, 2022
Potential drug-drug interaction of olverembatinib (HQP1351) using physiologically based pharmacokinetic modelsZhiheng Yu, Zihan Lei, Xueting Yao, et al.
Frontiers in Oncology|October 12, 2020
A Novel Prognostic Scoring System Integrating Gene Expressions and Clinicopathological Characteristics to Predict Very Early Relapse in Node-Negative Estrogen Receptor-Positive/HER2-Negative Breast CancerCaijin Lin, Jiayi Wu, Lin Lin, et al.
Frontiers in Oncology|February 11, 2026
MiR-424-5p acts as an oncogene in Hep3B cells by activating the PI3K/AKT signaling pathwayZhixian Ding, Shuaiyong Qi, Mengxue Hu, et al.
Frontiers in Oncology|February 2, 2023
Impact of clinicopathological factors on extended endocrine therapy decision making in estrogen receptor-positive breast cancerWeilin Chen, Jiayi Wu, Yifei Zhu, et al.
Biomedical Physics & Engineering Express|February 5, 2021
Synthesizing CT images from MR images with deep learning: model generalization for different datasets through transfer learningWen Li, Samaneh Kazemifar, Ti Bai, et al.
Pageof 11